Janet F. Czachura - Concepedia

Author

Janet F. Czachura

Eli Lilly (United States)

Also Known As

J F Czachura, J.F. Czachura, Janet F Czachura, Janet F. Czachura

Publications

529

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Oklahoma Health Sciences Center Butler University

About

Janet F. Czachura is an author at Eli Lilly (United States) specializing in neuropharmacology, neuroscience, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	324
2	Neuroscience	8	8	344
3	Social Sciences	7	7	314
4	Health Sciences	2	2	75
5	Neurology	1	1	24

Janet F. Czachura

Publications

509

Citations

H-Index

Page 1

	Year	Citations
Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat Janet F. Czachura, Kurt Rasmussen Naunyn-Schmiedeberg s Archives of Pharmacology NeurophysiologyNeuroanatomyChronic AdministrationMedicineBehavioural Pharmacology	2000	94
The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons Kurt Rasmussen, Marsha E. Stockton, Janet F. Czachura European Journal of Pharmacology NeurophysiologyMedicinePhysiologyNeuropeptide ReceptorNeuropharmacology	1991	58
The Novel 5-Hydroxytryptamine1A Antagonist LY426965: Effects on Nicotine Withdrawal and Interactions with Fluoxetine Kurt Rasmussen, David O. Calligaro, Janet F. Czachura, Journal of Pharmacology and Experimental Therapeutics	2000	58
Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons. K. Rasmussen, Janet F. Czachura, Marsha E. Stockton, Journal of Pharmacology and Experimental Therapeutics	1993	56
Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity Kurt Rasmussen, Marsha E. Stockton, Janet F. Czachura, European Journal of Pharmacology PsychiatryMedicineDopamine Unit ActivityNeurotransmitterPsychopharmacology	1991	53
Nicotine withdrawal leads to increased sensitivity of serotonergic neurons to the 5-HT 1A agonist 8-OH-DPAT K. Rasmussen, Janet F. Czachura Psychopharmacology Tobacco ControlNicotine WithdrawalNeurophysiologyAddiction5-Ht 1A	1997	45
Central nervous system characterization of the new cholecystokininB antagonist LY288513 David R. Helton, James E. Berger, Janet F. Czachura, Pharmacology Biochemistry and Behavior MedicinePhysiologyNeurotransmitterNeuropeptide ReceptorNeuropharmacology	1996	30
The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle Kurt Rasmussen, Janet F. Czachura, Mary Jeanne Kallman, Neuroreport	1996	26
The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition Kurt Rasmussen, Mary Gates, James E Burger, Neuroscience Letters Cck-b Antagonist Ly288513Psychoactive DrugPsychiatryMedicinePsychopharmacology	1997	25
Spontaneous versus elicited seizures following ethanol withdrawal: Differential time course Larry P. Gonzalez, Janet F. Czachura, Kevin Brewer Alcohol Substance AbuseNeurophysiologyAddictionAlcohol DependenceRebound Effect	1989	24

Page 1